Product Code: ETC6736921 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, 2021 & 2031F |
3.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market - Industry Life Cycle |
3.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market - Porter's Five Forces |
3.5 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising awareness about regenerative medicine and its benefits in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for stem cell therapies in China |
4.3.2 Limited reimbursement policies for autologous stem cell and non-stem cell therapies |
4.3.3 High costs associated with stem cell-based treatments in China |
5 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends |
6 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Types |
6.1 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Autologous Stem Cells, 2021- 2031F |
6.1.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Autologous Non-Stem Cells, 2021- 2031F |
6.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Blood Pressure (BP) Monitoring Devices, 2021- 2031F |
6.2.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Pulmonary Pressure Monitoring Devices, 2021- 2031F |
6.2.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Intracranial Pressure (ICP) Monitoring Devices, 2021- 2031F |
6.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Neurodegenerative Disorders, 2021- 2031F |
6.3.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Cancer and Tumors, 2021- 2031F |
6.3.5 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenues & Volume, By Ambulatory Surgical Center, 2021- 2031F |
7 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Import-Export Trade Statistics |
7.1 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Export to Major Countries |
7.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Imports from Major Countries |
8 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Key Performance Indicators |
8.1 Number of clinical trials conducted in China for autologous stem cell and non-stem cell therapies |
8.2 Adoption rate of regenerative medicine technologies in Chinese hospitals |
8.3 Number of research collaborations between Chinese and international biotech companies in the field of stem cell therapies |
9 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market - Opportunity Assessment |
9.1 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market - Competitive Landscape |
10.1 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Revenue Share, By Companies, 2024 |
10.2 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |